If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

  • There is currently no data for CAU

Trading Update

18 Jan 2024 07:00

RNS Number : 0703A
Centaur Media PLC
18 January 2024
 

Centaur Media plc

Incorporated in England and Wales

Registration number: 04948078

LEI: 2138005WK87G7DQRQI62

ISIN: GB0034291418

 

18 January 2024

Centaur Media Plc

("Centaur" or the "Group")

Trading Update

Centaur, an international provider of business intelligence, learning and specialist consultancy, provides a trading update ahead of publishing its results for the full year ended 31 December 2023 ("FY23") on 13 March 2024.

Trading Update

The Board is pleased to report that the Group expects to deliver good year-on-year growth in both Adjusted EBITDA1 and Adjusted EBITDA1 margin in FY23, with revenue on a continuing2 basis slightly below that of FY22 due to a decline in non-strategic Marketing Solutions and Recruitment revenue.

The Group's Adjusted EBITDA1 performance for FY23 is expected to generate a margin above 25%, reflecting the ongoing focus on strategically valuable revenue streams3 and the operational leverage inherent within Centaur's business. Despite the uncertain macroeconomic backdrop and sector-wide challenges, this growth in Adjusted EBITDA1 margin exceeds Centaur's profitability target, set three years ago in line with its Margin Acceleration Plan 2023 ("MAP23").

The much-publicised macro-economic environment, trading conditions and inflationary pressures witnessed in FY23 resulted in revenue slowing in the second half of the year. Accordingly, the Board maintains a cautious outlook as we open 2024.

Centaur's net cash balance (including short-term deposits) stood at £9.5m as at 31 December 2023 (£16.0m as at 31 December 2022) after payment of £8.9m of ordinary and special dividends during FY23.

Swag Mukerji, Chief Executive Officer, commented:

"Centaur continues to perform well despite the macroeconomic uncertainty that characterised 2023 for our customers. During this time, we have taken financial and operational steps to improve the efficiency of our business and I am very pleased that we have exceeded the profit margin target set out over 3 years ago.

"I am particularly proud that, despite the extreme upheaval of the last few years, we have significantly grown our profits and built a business with a high proportion of strategically valuable revenue generated from blue-chip customers. This provides a strong platform for our future strategy, which we will outline following our preliminary results."

-Ends-

 

1 Adjusted EBITDA is adjusted operating profit before depreciation and amortisation. Adjusted results exclude adjusting items, such as amortisation of acquired intangible assets, as detailed in note 4 of the Interim Report for the period ended 30 June 2023.

2 In December 2023, Centaur closed the Really B2B and Design Week brands within Xeim. On this basis, these brands will be disclosed in the 2023 annual report as discontinued operations and the FY22 results re-presented accordingly. The re-presented FY22 Group revenue on a continuing basis is £38.4m.

3 Centaur's strategically valuable revenue streams comprise Premium Content, Training and Advisory, and Events.

 

Enquiries

Centaur Media Plc

020 7970 4000

Swag Mukerji, Chief Executive Officer

Simon Longfield, Chief Financial Officer

Teneo

Zoë Watt

07713 157561

Note to editors

Centaur is an international provider of business intelligence, learning and specialist consultancy that helps ambitious leaders see around corners and deliver change in the Marketing and Legal verticals. Our suite of brands, which includes Econsultancy, Marketing Week, MW Mini MBA, Festival of Marketing, Influencer Intelligence and The Lawyer, provide deep sector expertise across the Marketing and Legal industries based on our customers' needs.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUBSWRSUUAAAR
Date   Source Headline
20th Oct 201112:30 pmRNSDirector/PDMR Shareholding
20th Oct 201112:30 pmRNSDirector/PDMR Shareholding
13th Oct 20117:00 amRNSInvestor Day
11th Oct 20117:00 amRNSDirectorate Change
7th Oct 201112:41 pmRNSNotification of major interest in shares
3rd Oct 20117:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
3rd Oct 20117:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
3rd Oct 20117:00 amRNSTotal Voting Rights
29th Sep 201111:29 amRNSDirector/PDMR Shareholding
20th Sep 20112:53 pmRNSDirector/PDMR Shareholding
20th Sep 20112:52 pmRNSDirector/PDMR Shareholding
16th Sep 20119:29 amRNSDirector Dealing
16th Sep 20119:28 amRNSDirector Dealing
16th Sep 20117:00 amRNSDirector/PDMR Shareholding
15th Sep 20113:21 pmRNSDirector Dealing
15th Sep 20113:15 pmRNSDirector's Dealings
15th Sep 20117:00 amRNSFinal Results
22nd Aug 20114:06 pmRNSDirector/PDMR Shareholding
22nd Aug 20114:01 pmRNSDirector/PDMR Shareholding
22nd Aug 20117:00 amRNSAcquisition
1st Aug 20119:35 amRNSNotice of Results
22nd Jul 201112:17 pmRNSNotification of major interest in shares
21st Jul 20111:06 pmRNSOperating board appointment
20th Jul 20112:50 pmRNSPRMR Shareholding
20th Jul 20112:46 pmRNSPDMR Shareholding
14th Jul 20117:00 amRNSPre-close trading statement
13th Jul 201111:53 amRNSNotification of major issue in shares
30th Jun 201112:34 pmRNSDirector/PDMR Shareholding
29th Jun 20119:26 amRNSDirector/PDMR Shareholding
28th Jun 20117:00 amRNSRestructuring
20th Jun 20115:35 pmRNSDirector/PDMR Shareholding
20th Jun 20115:33 pmRNSDirector/PDMR Shareholding
10th Jun 20118:30 amRNSDirector/PDMR Shareholding
2nd Jun 20117:00 amRNSDirectorate Change
19th May 20115:37 pmRNSDirector/PDMR Shareholding
19th May 20115:34 pmRNSDirector/PDMR Shareholding
11th May 20117:00 amRNSInterim Management Statement
6th Apr 201111:59 amRNSAcquisition
22nd Mar 201110:40 amRNSDirector/PDMR Shareholding
22nd Mar 201110:37 amRNSDirector/PDMR Shareholding
22nd Mar 201110:35 amRNSDirector/PDMR Shareholding
24th Feb 20117:00 amRNSHalf Yearly Report
6th Jan 20117:00 amRNSHalf Year trading update
17th Nov 201012:08 pmRNSInterim Management Statement
16th Sep 20107:00 amRNSFinal Results
8th Jul 20107:00 amRNSPre-Close Trading Statement
23rd Jun 201011:25 amRNSDirector/PDMR Shareholding
23rd Jun 201011:17 amRNSDirector/PDMR Shareholding
1st Jun 201010:00 amRNSAcquisition of TaxBriefs for ?1.9 m
12th May 20107:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.